6 completed. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
Follow Vaxigrip®: new trials by email Literature Review of Vaxigrip® trials Research Report on Vaxigrip®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Routes of Immunization and Flu Immune Responses INTANZA® 15, Vaxigrip®, INTANZA® 15 T - Influenza | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 60 | 2012-10-01 | 2013-08-05 |
| Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore CYD Dengue vaccine, NaCl + influenza virus or hepatitis A vaccine - Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 1198 | 2009-04-07 | 2022-03-21 |
| Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects Inactivated, split-virion influenza virus - Influenza, Orthomyxoviridae Infections | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 62 | 2007-11-01 | 2014-01-14 |
| Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines Inactivated, split-virion, influenza vaccine, Inactivated, split-virion influenza vaccine - Influenza, Orthomyxovirus Infections | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 160 | 2007-09-01 | 2015-06-17 |
| Immunogenicity Study of the Influenza Vaccine in Adults Inactivated, split-virion influenza vaccine, Inactivated, split-virion, influenza virus - Orthomyxoviridae Infections, Influenza | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 978 | 2005-09-01 | 2014-01-14 |
| Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults Inactivated, split-virion influenza vaccine - Influenza, Orthomyxoviridae Infection | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 1150 | 2003-09-01 | 2014-01-13 |
Influenza, Human (5) · Orthomyxoviridae Infections (4) · Dengue (1) · Severe Dengue (1)
Sanofi Pasteur, a Sanofi Company (5) · Assistance Publique - Hôpitaux de Paris (1)
France (3) · Belgium (2) · Czechia (1) · Germany (1) · Lithuania (1) · Singapore (1) · Switzerland (1)
PMID 19261173, PMID 19341446, PMID 22894958, PMID 23839107, PMID 25483667, PMID 30843873
2014 (1)